Latest & greatest articles for obesity

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on obesity or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on obesity and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for obesity

981. Gastric pacing (gastric electrical stimulation) for the treatment of obesity - early assessment briefs (Alert)

Gastric pacing (gastric electrical stimulation) for the treatment of obesity - early assessment briefs (Alert) Gastric pacing (gastric electrical stimulation) for the treatment of obesity - early assessment briefs (Alert) Gastric pacing (gastric electrical stimulation) for the treatment of obesity - early assessment briefs (Alert) Swedish Council on Technology Assessment in Health Care Record Status This is a bibliographic record of a published health technology assessment from a member (...) of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Swedish Council on Technology Assessment in Health Care. Gastric pacing (gastric electrical stimulation) for the treatment of obesity - early assessment briefs (Alert) Stockholm: Swedish Council on Technology Assessment in Health Care (SBU) 2004 Authors' objectives This review aims to assess the available evidence on gastric pacing (gastric electrical stimulation) for the treatment of obesity. Gastric

Health Technology Assessment (HTA) Database.2004

982. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement Avenell A, Broom J, Brown T J, Poobalan A, Aucott L, Stearns S C, et al Record Status (...) This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Avenell A, Broom J, Brown T J, Poobalan A, Aucott L, Stearns S C, et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technology Assessment 2004; 8(21): 1-194 Authors' objectives The objectives of this review were: 1. To review

Health Technology Assessment (HTA) Database.2004

983. Pharmacological and surgical treatment of obesity

Pharmacological and surgical treatment of obesity Pharmacological and surgical treatment of obesity Pharmacological and surgical treatment of obesity Shekelle PG, Morton SC, Maglione MA, Suttorp M, Tu W, Li Z Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Shekelle PG, Morton SC, Maglione MA, Suttorp M, Tu W, Li Z. Pharmacological (...) and surgical treatment of obesity. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 103. 2004 Authors' objectives The aim of this report was to assess the efficacy and safety of the weight loss medications sibutramine, orlistat, fluoxetine, phentermine, and diethylpropion; to assess the evidence for other medications that have been used for weight loss including bupropion, zonisamide, topiramate, and sertraline; and to assess the efficacy and safety

Health Technology Assessment (HTA) Database.2004

984. Management of obesity in childhood

Management of obesity in childhood Management of obesity in childhood Management of obesity in childhood Malaysian Health Technology Assessment Unit Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Malaysian Health Technology Assessment Unit. Management of obesity in childhood. Kuala Lumpur: Malaysian Health Technology Assessment Unit (MHTAU) 2004 Authors (...) ' objectives To assess the safety, effectiveness, and cost implications of management of obesity in childhood. Authors' conclusions Prevention: There is insufficient evidence to recommend in favour of or against community-based obesity prevention programs. However, in view of the major health risk associated with obesity, and the limited long-term effectiveness of weight-reduction methods, the prevention of obesity should be a high priority for health care providers. Screening methods: BMI is recommended

Health Technology Assessment (HTA) Database.2004

985. Family-based interventions for childhood obesity: a review

Family-based interventions for childhood obesity: a review Family-based interventions for childhood obesity: a review Family-based interventions for childhood obesity: a review Berry D, Sheehan R, Heschel R, Knafl K, Melkus G, Grey M CRD summary This review assessed family-based interventions for childhood obesity. The authors stated that it was difficult to draw conclusions since most of the studies had methodological flaws. There were limitations to the review itself, but the authors drew (...) no firm overall conclusions; this reflects the paucity of evidence from a small number of generally poor-quality studies. Authors' objectives To assess family-based interventions for childhood obesity. Searching MEDLINE, PsycLIT and CINAHL were searched for studies published in English from 1980 to January 2004; the search terms were reported. No attempts were made to locate unpublished studies. In addition, five named relevant journals were searched. Study selection Study designs of evaluations

DARE.2004

986. Cost-effectiveness of sibutramine in the treatment of obesity

Cost-effectiveness of sibutramine in the treatment of obesity Cost-effectiveness of sibutramine in the treatment of obesity Cost-effectiveness of sibutramine in the treatment of obesity Warren E, Brennan A, Akehurst R Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study (...) and the conclusions drawn. Health technology The study examined the addition of sibutramine (SIB) to diet and lifestyle advice for the treatment of obesity, over a 1-year period. SIB was given at a dosage of 10 mg. Responders, defined as patients who lose 2 kg after 1 month and 5% of their initial weight after 3 months, continued treatment on a dosage of 10 mg for 12 months. Initial nonresponders (at 3 months) were given SIB at a dosage of 15 mg for a further 3-month period. Patients who failed again to reach

NHS Economic Evaluation Database.2004

987. Usefulness of surgical treatments for obesity

Usefulness of surgical treatments for obesity Usefulness of surgical treatments for obesity Usefulness of surgical treatments for obesity Pichon Riviere A, Augustovski F, Ferrante D, Garcia Marti S, Glujovsky D, Lopez A, Regueiro A Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Pichon Riviere A, Augustovski F, Ferrante D, Garcia Marti S (...) , Glujovsky D, Lopez A, Regueiro A. Usefulness of surgical treatments for obesity. Ciudad de Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS) 2004 Authors' objectives The aim of this study was to assess the efficacy and safety of different surgical techniques in the treatment of morbid obesity Authors' conclusions Although the available evidence suggests a greater weight loss with surgical treatments than with non-surgical, no conclusive data has been found as regards

Health Technology Assessment (HTA) Database.2004

988. Surgical treatments for morbid obesity

Surgical treatments for morbid obesity Surgical treatments for morbid obesity Surgical treatments for morbid obesity Adams E Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Adams E. Surgical treatments for morbid obesity. VA Technology Assessment Program (VATAP). 2004 Authors' objectives This study aims to provide a bibliographic list (...) of completed health technology assessments and relevant literature on surgical treatments for morbid obesity. Project page URL Indexing Status Subject indexing assigned by CRD MeSH Gastric Bypass; Gastroplasty; Obesity /surgery; Obesity, Morbid /surgery Language Published English Country of organisation United States Address for correspondence VA Medical Center (152-M), 150 South Huntington Avenue, Boston, MA 02130 USA. Tel: +1 617 278 4469; Fax: +1 617 232 6140; Email: karen.flynn@med.va.gov

Health Technology Assessment (HTA) Database.2004

989. Rimonabant for smoking cessation, weight loss and cardiovascular risk factors of overweight/obesity - horizon scanning review

Rimonabant for smoking cessation, weight loss and cardiovascular risk factors of overweight/obesity - horizon scanning review Rimonabant for smoking cessation, weight loss and cardiovascular risk factors of overweight/obesity - horizon scanning review Rimonabant for smoking cessation, weight loss and cardiovascular risk factors of overweight/obesity - horizon scanning review NHSC Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA (...) . No evaluation of the quality of this assessment has been made for the HTA database. Citation NHSC. Rimonabant for smoking cessation, weight loss and cardiovascular risk factors of overweight/obesity - horizon scanning review. Birmingham: National Horizon Scanning Centre (NHSC). 2004 Authors' objectives To summarise the currently available evidence on rimonabant for smoking cessation, weight loss and cardiovascular risk factors of overweight/obesity. Authors' conclusions Rimonabant (Acomplia) is a selective

Health Technology Assessment (HTA) Database.2004

990. Gastric pacing (gastric electrical stimulation) for the treatment of obesity

Gastric pacing (gastric electrical stimulation) for the treatment of obesity Gastric pacing (gastric electrical stimulation) for the treatment of obesity We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Swedish Agency for Health Technology Assessment and Assessment of Social Services Gastric pacing (gastric electrical stimulation) for the treatment of obesity Share: Reading time approx. 4 minutes This document was published more (...) than 2 years ago. The nature of the evidence may have changed. Findings by SBU Alert Version : 1 Technology and target group Gastric pacing is a new method to treat obesity by electrical stimulation of the stomach by means of an implanted electrode. The pulse generator, which looks like an ordinary cardiac pacemaker, is implanted subcutaneously. The pacemaker electrode is surgically implanted in the stomach wall. The procedure, which is performed laparoscopically (keyhole surgery), is suitable

Swedish Council on Technology Assessement2004

991. Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial.

Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial. 15107313 2004 05 24 2004 06 02 2014 06 09 1756-1833 328 7450 2004 May 22 BMJ (Clinical research ed.) BMJ Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial. 1237 To determine if a school based educational programme aimed at reducing consumption of carbonated drinks can prevent excessive weight gain in children. Cluster (...) randomised controlled trial. Six primary schools in southwest England. 644 children aged 7-11 years. Focused educational programme on nutrition over one school year. Drink consumption and number of overweight and obese children. Consumption of carbonated drinks over three days decreased by 0.6 glasses (average glass size 250 ml) in the intervention group but increased by 0.2 glasses in the control group (mean difference 0.7, 95% confidence interval 0.1 to 1.3). At 12 months the percentage of overweight

BMJ2004 Full Text: Link to full Text with Trip Pro

992. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial.

Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. 15213209 2004 06 23 2004 06 28 2016 10 17 1538-3598 291 24 2004 Jun 23 JAMA JAMA Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. 2978-84 Healthy lifestyle factors are associated with maintenance of erectile function in men. To determine the effect of weight loss and increased physical activity on erectile and endothelial functions in obese men (...) . Randomized, single-blind trial of 110 obese men (body mass index > or =30) aged 35 to 55 years, without diabetes, hypertension, or hyperlipidemia, who had erectile dysfunction that was determined by having a score of 21 or less on the International Index of Erectile Function (IIEF). The study was conducted from October 2000 to October 2003 at a university hospital in Italy. The 55 men randomly assigned to the intervention group received detailed advice about how to achieve a loss of 10% or more

JAMA2004

993. Screening for obesity in adults: recommendations and rationale.

Screening for obesity in adults: recommendations and rationale. This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on screening for obesity in adults based on the USPSTF's examination of evidence specific to obesity and overweight in adults and updates the 1996 recommendations on this topic. The complete USPSTF recommendation and rationale statement on this topic, which includes a brief review of the supporting evidence, is available through the USPSTF

Annals of Internal Medicine2003

994. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning.

Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. BACKGROUND: Impaired glucose tolerance is common among obese adolescents, but the changes in insulin sensitivity and secretion that lead to this prediabetic state are unknown. We investigated whether altered partitioning of myocellular and abdominal fat relates to abnormalities in glucose homoeostasis in obese adolescents with prediabetes (...) . METHODS: We studied 14 obese children with impaired glucose tolerance and 14 with normal glucose tolerance, of similar ages, sex distribution, and degree of obesity. Insulin sensitivity and secretion were assessed by the euglycaemic-hyperinsulinaemic clamp and the hyperglycaemic clamp. Intramyocellular lipid was assessed by proton nuclear magnetic resonance spectroscopy and abdominal fat distribution by magnetic resonance imaging. FINDINGS: Peripheral glucose disposal was significantly lower

Lancet2003 Full Text: Link to full Text with Trip Pro

995. Obesity: associations with acute mountain sickness.

Obesity: associations with acute mountain sickness. BACKGROUND: Although few retrospective studies of high altitude have reported that obesity might be associated with the development of acute mountain sickness (AMS), this association has not been studied prospectively. OBJECTIVE: To determine whether obesity is associated with the development of AMS. DESIGN: Obese and nonobese men were compared at a simulated altitude of 3658 m (12 000 ft). SETTING: 24 hours in a hypobaric environmental (...) chamber. PARTICIPANTS: 9 obese and 10 nonobese men. MEASUREMENTS: Percentage body fat (by hydrostatic weighing), Lake Louise AMS score, and Sao2 level (by pulse oximetry) were measured. RESULTS: Average AMS scores increased more rapidly with time spent at simulated high altitudes for obese men than for nonobese men (P < 0.001). The response of Sao2 with exposure differed between nonobese and obese men. After 24 hours in the altitude chamber, seven obese men (78%) and four nonobese men (40%) had AMS

Annals of Internal Medicine2003

996. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms.

Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. CONTEXT: Gastroesophageal reflux and obesity are both increasing in prevalence. The scientific evidence for an association between these conditions is sparse and contradictory. A difference between sexes concerning this relation has been proposed. OBJECTIVE: To evaluate the relation between body mass and gastroesophageal reflux symptoms and determine how this relation is influenced by female sex hormones. DESIGN (...) logistic regression, with odds ratios (ORs) and 95% confidence intervals (CIs) as measures of association. RESULTS: There was a dose-response association between increasing body mass index (BMI) and reflux symptoms in both sexes (P for trend <.001), with a significantly stronger association in women (P<.001). Compared with those with a BMI less than 25, the risk of reflux was increased significantly among severely obese (BMI >35) men(OR, 3.3; 95% CI, 2.4-4.7) and women (OR, 6.3; 95% CI, 4.9

JAMA2003

997. Obesity in general elective surgery.

Obesity in general elective surgery. BACKGROUND: Obese patients are generally believed to be at a higher risk for surgery than those who are not obese, although convincing data are lacking. METHODS: We prospectively investigated a cohort of 6336 patients undergoing general elective surgery at our institution to assess whether obesity affects the outcome of surgery. Exclusion criteria were emergency, vascular, thoracic, and bariatric operations; transplantation procedures; patients under (...) immunosuppression; and operations done under local anaesthesia. Postoperative morbidity was analysed for non-obese and obese patients (body-mass index <30 kg/m(2) vs >or=30 kg/m(2)). Obesity was further stratified into mild obesity (30.0-34.9 kg/m(2)) and severe obesity (>or=35 kg/m(2)). Risk factors were analysed with univariate and multivariate models. FINDINGS: The cohort consisted of 6336 patients, of whom 808 (13%) were obese, 569 (9%) were mildly obese, and 239 (4%) had severe obesity

Lancet2003

998. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. BACKGROUND: The influence of excess body weight on the risk of death from cancer has not been fully characterized. METHODS: In a prospectively studied population of more than 900,000 U.S. adults (404,576 men and 495,477 women) who were free of cancer at enrollment in 1982, there were 57,145 deaths from cancer during 16 years of follow-up. We examined the relation in men and women between (...) the body-mass index in 1982 and the risk of death from all cancers and from cancers at individual sites, while controlling for other risk factors in multivariate proportional-hazards models. We calculated the proportion of all deaths from cancer that was attributable to overweight and obesity in the U.S. population on the basis of risk estimates from the current study and national estimates of the prevalence of overweight and obesity in the U.S. adult population. RESULTS: The heaviest members of this cohort

NEJM2003

999. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women.

Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. CONTEXT: Current public health campaigns to reduce obesity and type 2 diabetes have largely focused on increasing exercise, but have paid little attention to the reduction of sedentary behaviors. OBJECTIVE: To examine the relationship between various sedentary behaviors, especially prolonged television (TV) watching, and risk of obesity and type 2 diabetes in women. DESIGN (...) , SETTING, AND PARTICIPANTS: Prospective cohort study conducted from 1992 to 1998 among women from 11 states in the Nurses' Health Study. The obesity analysis included 50 277 women who had a body mass index (BMI) of less than 30 and were free from diagnosed cardiovascular disease, diabetes, or cancer and completed questions on physical activity and sedentary behaviors at baseline. The diabetes analysis included 68 497 women who at baseline were free from diagnosed diabetes mellitus, cardiovascular

JAMA2003

1000. Health-related quality of life of severely obese children and adolescents.

Health-related quality of life of severely obese children and adolescents. CONTEXT: One in 7 US children and adolescents is obese, yet little is known about their health-related quality of life (QOL). OBJECTIVE: To examine the health-related QOL of obese children and adolescents compared with children and adolescents who are healthy or those diagnosed as having cancer. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study of 106 children and adolescents (57 males) between the ages of 5 (...) and 18 years (mean [SD], 12.1 [3] years), who had been referred to an academic children's hospital for evaluation of obesity between January and June 2002. Children and adolescents had a mean (SD) body mass index (BMI) of 34.7 (9.3) and BMI z score of 2.6 (0.5). MAIN OUTCOME MEASURES: Child self-report and parent proxy report using a pediatric QOL inventory generic core scale (range, 0-100). The inventory was administered by an interviewer for children aged 5 through 7 years. Scores were compared

JAMA2003